Skip to main content
. 2022 Aug 9:M22-1503. doi: 10.7326/M22-1503

Figure 3. Time to sustained recovery and death through day 90 for ensovibep vs. placebo.

Figure 3. Time to sustained recovery and death through day 90 for ensovibep vs. placebo. The rate ratios were calculated with Fine–Gray models to account for the competing risk for death and stratified according to study pharmacy. Left. Sustained recovery. Right. Death.

The rate ratios were calculated with Fine–Gray models to account for the competing risk for death and stratified according to study pharmacy. Left. Sustained recovery. Right. Death.